1. Tang, Hao, Gong, Xiaoshan, Dai, Jingjin, Deng, Jiezhong, Dong, Shiwu. 2023. The IRF1/GBP5 axis promotes osteoarthritis progression by activating chondrocyte pyroptosis. In Journal of orthopaedic translation, 44, 47-59. doi:10.1016/j.jot.2023.11.005. https://pubmed.ncbi.nlm.nih.gov/38229660/
2. Zhou, Lei, Zhao, Han, Zhao, He, Tang, Yan, Zhang, Yiya. 2022. GBP5 exacerbates rosacea-like skin inflammation by skewing macrophage polarization towards M1 phenotype through the NF-κB signalling pathway. In Journal of the European Academy of Dermatology and Venereology : JEADV, 37, 796-809. doi:10.1111/jdv.18725. https://pubmed.ncbi.nlm.nih.gov/36367676/
3. Yu, Xiaoting, Jin, Jing, Zheng, Yanwen, Chen, Clark C, Li, Ming. 2021. GBP5 drives malignancy of glioblastoma via the Src/ERK1/2/MMP3 pathway. In Cell death & disease, 12, 203. doi:10.1038/s41419-021-03492-3. https://pubmed.ncbi.nlm.nih.gov/33608513/
4. Yao, Xiangyang, Liu, Wei, Li, Xiaofei, Ge, Shengxiang, Xia, Ningshao. 2022. Whole blood GBP5 protein levels in patients with and without active tuberculosis. In BMC infectious diseases, 22, 328. doi:10.1186/s12879-022-07214-8. https://pubmed.ncbi.nlm.nih.gov/35369870/
5. Che, Na, Zhang, Yang, Zhang, Shu, Yuan, Zengqiang, Liao, Yajin. 2024. Macrophagic HDAC3 inhibition ameliorates Dextran Sulfate Sodium induced inflammatory bowel disease through GBP5-NLRP3 pathway. In International journal of medical sciences, 21, 1385-1398. doi:10.7150/ijms.94592. https://pubmed.ncbi.nlm.nih.gov/38903915/
6. Cheng, Shun-Wen, Chen, Po-Chih, Lin, Min-Hsuan, Chiu, Hui-Wen, Lin, Yuan-Feng. 2021. GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer. In Biomedicines, 9, . doi:10.3390/biomedicines9040371. https://pubmed.ncbi.nlm.nih.gov/33916322/